Find trials
Search tips

Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysmotility – Autoimmune Type Registry

Overview

About this study

The purpose of this study is to create a research resource of GI motility patients with symptoms referable to JAG-A syndrome (Joint hypermobility, Autonomic dysfunction, Gastrointestinal dysmotility – Autoimmune type).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a suspected motility disorder, dysautonomia, rheumatic or autoimmune disease.

Exclusion Criteria: 

  • Inability to comply with study procedures (particularly completing questionnaires in a timely manner).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/30/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Pankaj Pasricha, M.B.B.S., M.D.

Open for enrollment

Contact information:

Guillermo Barahona Hernandez

(410) 603-8343

Barahona.Guillermo@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20554305

Mayo Clinic Footer